In a groundbreaking advancement in neuroscience technology, researchers from the Aerospace Information Research Institute at the Chinese Academy of Sciences have unveiled a state-of-the-art dual-mode wireless microsystem designed to simultaneously monitor electrophysiological activity and dopamine-related electrochemical signals within the brain. This innovative platform promises to illuminate the intricate neural mechanisms underlying pharmacological effects on cortical circuits by capturing real-time electrical and chemical brain dynamics, a feat that has long eluded scientists due to technical constraints.
Neuroscientific investigations often grapple with the challenge of correlating multidimensional neural signals that operate on different modalities. Electrophysiological recordings capture rapid neuronal spikes and local field potentials (LFPs), presenting a temporal resolution ideal for observing immediate neuronal events. However, these signals alone fail to convey the chemical milieu shaping neural behavior. Neurotransmitter dynamics, especially dopamine, play a crucial role in modulating brain function but require sensitive electrochemical detection methods for accurate monitoring. Historically, research platforms have predominantly focused on one modality—either electrophysiological or neurochemical—making it difficult to obtain a holistic understanding of brain states or drug effects.
The newly developed dual-mode microelectrode array tackles this limitation through a sophisticated electrode design. Using platinum nanoparticles (PtNPs) and poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS), the researchers engineered electrophysiological sites with enhanced conductivity and stability for precise spike and LFP recordings. Simultaneously, an electrochemical site tailored for dopamine sensing incorporates additional modifications with reduced graphene oxide (rGO) and Nafion, constructing a PtNPs/PEDOT:PSS/rGO/Nafion composite. This multi-layered structure significantly amplifies electrochemical sensitivity and ensures selectivity against common interferents such as uric acid, serotonin, ascorbic acid, and lactic acid.
On the hardware frontier, the team implemented a hybrid acquisition system that integrates a specialized electrophysiological chip alongside the AD5941 electrochemical front end. An intelligent dual-controller architecture comprising a field-programmable gate array (FPGA) paired with an ESP32 microcontroller orchestrates independent yet synchronized data capture and wireless transmission from both signal modalities. Critical to minimizing crosstalk and data corruption, electrophysiological and electrochemical data streams are transmitted simultaneously but via separate TCP ports. This architectural choice guarantees the temporal alignment and integrity of neural datasets, enabling researchers to dissect the interplay between electrical spikes, LFPs, and dopamine fluctuations with millisecond precision.
The comprehensive calibration and validation of this microsystem were first conducted in vitro. Dopamine calibration curves revealed a robust and linear electrochemical response, confirming the device’s sensitivity and dynamic range. Notably, selectivity tests demonstrated the system’s ability to discriminate dopamine oxidation currents amidst a cocktail of neurochemical interferents, ensuring fidelity in complex biological environments. Furthermore, wireless transmission integrity was rigorously assessed, demonstrating accurate data delivery across distances up to 25 meters with negligible latency or packet loss, underscoring the device’s suitability for freely moving animal experiments without tethers.
Translating these advances into a live animal model, the researchers implanted the dual-mode microsystem into the prelimbic (PrL) cortex of rats. This brain region is integral to executive functions and is sensitive to neuropharmacological modulation. By administering dexmedetomidine—a sedative with known but paradoxical and poorly understood effects on cortical activity—the team pursued a dynamic interrogation of neural electrical firing patterns alongside dopamine fluctuations. This sophisticated approach exposed nuanced dose-dependent changes: higher doses correlated with reduced spike firing rates and dampened peak-to-peak amplitudes, suppressed overall LFP power, increased delta-frequency activity (associated with decreased arousal), and reduced gamma oscillations, indicative of a reconfigured cortical state consistent with sedation.
Simultaneously, electrochemical monitoring unveiled an increase in amperometric signals related to dopamine concentrations as dexmedetomidine dosage escalated. This parallel observation of neurochemical enhancement accompanying electrophysiological suppression substantiates the microsystem’s capability to capture the complex, multifaceted neural correlates of sedation. Importantly, control saline conditions elicited minimal changes, affirming system specificity and the physiological relevance of the recorded responses. These findings reveal the microsystem’s potential as a powerful investigative tool for understanding the neurochemical underpinnings of anesthetic action and cortical state transitions.
The scientific implications of this dual-mode wireless microsystem are profound. Unlike prior single-modality or tethered platforms, this technology conserves 32 independent electrophysiological channels at high sampling rates while integrating dopamine-sensitive electrochemical pathways within the same device footprint. The dual-TCP wireless architecture enables real-time, synchronized acquisition and visualization of electrical and chemical signals, overcoming longstanding barriers in multimodal neural monitoring. Such comprehensive systems are invaluable for probing the mechanistic interactions between neural circuit activity and neurotransmitter dynamics under pharmacological challenges.
Looking forward, despite its remarkable performance, the current microsystem has limitations that present rich avenues for refinement. The modest in vivo sample size tempers broad generalization of the reported electrophysiological and dopamine-related observations. Amperometric readings in vivo remain susceptible to confounding factors such as electrode fouling, baseline drift, shifts in local pH or oxygenation, tissue inflammatory responses, and reference electrode stability. Thus, the data are best interpreted as dopamine-correlated signals rather than exact dopamine quantifications in extracellular space. Furthermore, the system currently relies on commercial electronic components, which constrain further miniaturization. It also lacks integrated stimulation or closed-loop modulation functionalities, which are critical for advanced neuromodulation studies.
Future developments aspire to embed dedicated, custom-fabricated integrated circuits that will shrink device size and power consumption. Incorporation of multimodal closed-loop control systems will enable responsive neurochemical-electrical feedback interventions, enhancing therapeutic and experimental utility. Expanding recording capacity to encompass multiple brain regions simultaneously will provide a more comprehensive spatial map of neurophysiological network dynamics. Cross-validation with orthogonal neurochemical detection modalities could further bolster confidence in dopamine measurements. Together, these advances would propel the technology from a sophisticated measurement tool to an instrumental platform for neurological disease research, neurorehabilitation, and cognitive neuroscience.
The research team responsible for this innovation includes Peiyao Jiao, Yilin Song, Jin Shan, Yu Liu, Qianli Jia, Qi Li, Ying Wang, Yan Luo, Pengfei Zhao, Juntao Liu, Zhenchang Wang, Mixia Wang, and Xinxia Cai. Their work represents a significant leap toward decrypting the intertwined electrical and chemical language of the brain in vivo, promising to inspire future explorations into neural circuit regulation and pharmacodynamics.
This pioneering study titled “A Dual-Mode Wireless Microsystem for Monitoring Dopamine and Spike Changes with Dexmedetomidine” was published on May 21, 2026, in the journal Cyborg and Bionic Systems. It was supported by funding from the National Natural Science Foundation of China, the Major Program of Scientific and Technical Innovation 2030, the Chinese Academy of Sciences Joint Foundation Program, and the Natural Science Foundation of Beijing.
Subject of Research: Dual-mode wireless monitoring of electrophysiological and dopamine-related electrochemical signals in vivo under pharmacological modulation.
Article Title: A Dual-Mode Wireless Microsystem for Monitoring Dopamine and Spike Changes with Dexmedetomidine
News Publication Date: May 21, 2026
Image Credits: Peiyao Jiao, Aerospace Information Research Institute, Chinese Academy of Sciences
Keywords
Neural monitoring, dopamine sensing, electrophysiology, wireless microsystem, dexmedetomidine, neurochemistry, brain-computer interfaces, electrode modification, dual-mode recording, neuropharmacology, local field potentials, neural circuits
Login
